Prescription drug · ANDA
Amoxicillin NDC 76420-138
Amoxicillin 875 mg/1 · Tablet, Coated · Oral · Asclemed USA, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 76420-138-20 | 76420013820 | 20 TABLET, COATED in 1 BOTTLE (76420-138-20)Marketed from Mar 4, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Amoxicillin
- Generic name (nonproprietary)
- amoxicillin
- Active ingredients
- Amoxicillin — 875 mg/1
- Dosage form
- Tablet, Coated
- Route
- Oral
- Labeler
- Asclemed USA, Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 065255
- Marketing start
- Listing expires
- Other FDA classes
- Penicillins (Chemical structure)
- Identifiers
- Product ID 76420-138_d964632f-4590-9500-e053-2995a90a992dSPL ID d964632f-4590-9500-e053-2995a90a992dSPL set ID 23b7a1fe-4e23-44ec-bc51-5209427c88ceRxCUI 308194UNII 804826J2HU
- Pharmacologic class
- Penicillin-class Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N476420013820followed by a unit qualifier and the quantityPackage 76420-0138-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, Amoxicillin Tablets should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data,local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Amoxicillin Tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of the designated bacteria in the conditions listed below: Amoxi…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 065255
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Amoxicillin | Amoxicillin 875 mg/1 | Tablet, CoatedOral | A-S Medication Solutions | 50090-5863 |
| Amoxicillin | Amoxicillin 875 mg/1 | Tablet, CoatedOral | A-S Medication Solutions | 50090-5880 |
| Amoxicillin | Amoxicillin 875 mg/1 | Tablet, CoatedOral | Hikma Pharmaceuticals USA Inc. | 0143-9285 |
| Amoxicillin | Amoxicillin 875 mg/1 | Tablet, CoatedOral | Proficient Rx LP | 82804-200 |
| Amoxicillin | Amoxicillin 875 mg/1 | Tablet, CoatedOral | NuCare Pharmaceuticals, Inc. | 68071-3716 |
| Amoxicillin | Amoxicillin 875 mg/1 | Tablet, CoatedOral | Preferred Pharmaceuticals Inc. | 68788-4062 |
| Amoxicillin | Amoxicillin 875 mg/1 | Tablet, CoatedOral | PD-Rx Pharmaceuticals, Inc. | 43063-885 |
| Amoxicillin | Amoxicillin 875 mg/1 | Tablet, CoatedOral | PD-Rx Pharmaceuticals, Inc. | 72789-224 |
| Amoxicillin | Amoxicillin 875 mg/1 | Tablet, CoatedOral | Redpharm Drug | 67296-2328 |